NIACINAMIDE 4% / TRIAMCINOLONE ACETONIDE 0.1%
- Manufacturer
- Sincerus Florida, LLC
- Effective date
- 2019-05-13
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:28:42
Label at a glance#
ProductNIACINAMIDE 4% / TRIAMCINOLONE ACETONIDE 0.1%
Active ingredientNIACINAMIDE, TRIAMCINOLONE ACETONIDE
Label structure4 sections
Label contents#
Full prescribing information#
Sincerus Florida, LLC. Adverse reactions
Active, inactive
NDC 72934- 2166-2 NIACINAMIDE 4% / TRIAMCINOLONE ACETONIDE 0.1%. Cream 30gm.
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| TRIAMCINOLONE ACETONIDE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d4d7da1a-7fd4-628e-cdae-89e749b1c534 | Product name | 7 | 20260127 |
| 75f7e47b-8736-a182-fc44-22aca8d79689 | Product name | 2 | 20251211 |
| 62986c8d-91f1-b1ba-b5a3-8b54b75bb8c2 | Product name | 6 | 20250516 |
| e42f429b-c4e5-0402-e1c5-730154df4060 | Product name | 4 | 20240205 |
| 38d4de13-64b3-4057-b91c-4b5126962341 | Product name | 1 | 20220516 |
| 089e0644-1ea8-8654-4113-39f960dd57d5 | Product name | 3 | 20210115 |
| 1629e00f-54fb-4a43-8306-b58442b23902 | Product name | 9 | 20200430 |
| 5331c9c8-f64b-11e6-ccf1-071c477fcb0b | Product name | 7 | 20190612 |
| 9f64e0dc-109c-9660-8e0e-91ec987b3817 | Product name | 6 | 20171204 |
| dfa879a3-32de-49f0-a7ba-9b9c3e13002f | Product name | 1 | 20171204 |
| 8de20f81-8411-4cf1-a8b2-03404ee56d01 | Product name | 3 | 20171109 |
| a5f1a68c-0352-4f34-46a3-9b4eed239ed8 | Product name | 2 | 20160819 |
| 355b2224-0895-7135-83f5-d099a6a82a0a | Product name | 1 | 20140508 |
| 55be6b50-8cc0-f0f1-74a1-3416a91193aa | Product name | 1 | 20140508 |
| 7a0092d1-1e8c-0d78-4f8d-d95fa15cc3cf | Product name | 1 | 20140508 |
| 89b93c13-4be8-69f3-b33b-63e64feffb9b | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72934-2166-2 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-58cb-a910-e053-dadaa90a0b85 | NIACINAMIDE 4% / TRIAMCINOLONE ACETONIDE 0.1% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72934-2166-2 | NIACINAMIDE 4% / TRIAMCINOLONE ACETONIDE 0.1% | 30 g in 1 BOTTLE, PUMP | CREAM | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72934-2166 | NIACINAMIDE 4% / TRIAMCINOLONE ACETONIDE 0.1% CREAM [SINCERUS FLORIDA, LLC] | 1 | Legacy NDC, 1 package rows | 20190514_88c5dc1c-a770-0577-e053-2a95a90a4258.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72934-2166-2 | GM - Gram | 72934-2166 | fc16b12e-c3ec-4ddd-8224-ecdf8b3a86e4 | 1 | 2020-03-10 |
Products#
Every source-derived product name is available through these pages.
- NIACINAMIDE 4% / TRIAMCINOLONE ACETONIDE 0.1%
- NIACINAMIDE
- TRIAMCINOLONE ACETONIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72934-2166 | 72934-2166-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
| TRIAMCINOLONE ACETONIDE | F446C597KA | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 88c5dc1c-a771-0577-e053-2a95a90a4258 | 88c5dc1c-a770-0577-e053-2a95a90a4258 | 2019-05-13 | Adverse reactions | 88c5dc1c-a771-0577-e053-2a95a90a4258 88c5dc1c-a770-0577-e053-2a95a90a4258 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


